EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Differential roles of Rad18 in repressing carcinogen- and oncogene-driven mutagenesis in vivo

Jay R Anand iD, Bethany Wagner Brown, Jitong Lou, Qisheng Gu, Yang Yang, Gaith Droby, Di Wu iD, Akankshya Jena, Jialiu Xie, Yuri Fedoriw, Bernard Weissman, Scott Williams und 1 weitere

NAR Cancer · 2026

DOI: 10.1093/narcan/zcag001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, 2026. Verfasst von Jay R Anand und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States. Hauptthemen laut MEDLINE: Carcinogens, DNA-Binding Proteins, Carcinoma, Squamous Cell, Mutagenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NCI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The DNA repair protein RAD18 activates “Y-family” trans-lesion synthesis (TLS) DNA polymerases that are DNA damage-tolerant and potentially error-prone. RAD18 is also frequently overexpressed and pathologically activated in cancer cells. However, the extent to which RAD18 shapes cancer genomes and impacts tumorigenesis is unclear. Therefore, we tested the effect of Rad18 status on chemically induced and oncogene-driven tumorigenesis. In a chemically induced oral carcinogenesis model, acute (2–16 days) 4NQO treatment induces expression of Rad18 and TLS polymerase mRNAs in mouse oral epithelial cells prior to the emergence of oral squamous cell carcinomas (OSCCs). Chronic (8-week) 4NQO treatment leads to the onset of oral tumors that is accelerated in Rad18−/− mice when compared with Rad18+/+ animals. Analysis of OSCC exomes reveals increased levels of G(C)>T(A) transversions in Rad18−/− tumors when compared with Rad18+/+. Therefore, Rad18 promotes error-free bypass of 4NQO-induced DNA lesions and suppresses 4NQO-induced oral carcinogenesis. In a KrasG12D-induced lung carcinogenesis model, Rad18 deficiency did not affect rates or incidence of oncogene-induced lung tumors or mutations. Taken together, we demonstrate that Rad18 has context-specific tumor-suppressive activity. Given the prevalence of 4NQO-like environmental exposures, RAD18 is highly likely to shape human cancer genomes and perhaps influence other aspects of the tumorigenic process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinogensDNA-Binding ProteinsCarcinoma, Squamous CellMutagenesisMouth NeoplasmsOncogenesAnimalsMice4-Nitroquinoline-1-oxideUbiquitin-Protein LigasesTranslesion DNA SynthesisMice, KnockoutCarcinogenesisDNA DamageDNA-Directed DNA PolymeraseHumans

Substanzen

CarcinogensDNA-Binding Proteins4-Nitroquinoline-1-oxideRad18 protein, mouseUbiquitin-Protein LigasesDNA-Directed DNA Polymerase

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
  • Division of Oral and Craniofacial Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
  • Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, NC 27599, United States.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.

ORCID-Profile: Jay R Anand, Di Wu

Förderung

  • NIEHS NIH HHS
  • NCI NIH HHS
  • NIAMS NIH HHS
  • National Institutes of Health
  • University Cancer Research Fund
  • UNC Center for Mental Health and Susceptibility

Zitieren

APA

Anand, J. R., Brown, B. W., Lou, J., Gu, Q., Yang, Y., Droby, G., Wu, D., Jena, A., Xie, J., Fedoriw, Y., Weissman, B., Williams, S., & Vaziri, C. (2026). Differential roles of Rad18 in repressing carcinogen- and oncogene-driven mutagenesis in vivo. NAR Cancer. https://doi.org/10.1093/narcan/zcag001

Vancouver

Anand JR, Brown BW, Lou J, Gu Q, Yang Y, Droby G, et al. Differential roles of Rad18 in repressing carcinogen- and oncogene-driven mutagenesis in vivo. NAR Cancer. 2026. doi:10.1093/narcan/zcag001

BibTeX
@article{Anand2026,
  author = {Anand, Jay R and Brown, Bethany Wagner and Lou, Jitong and Gu, Qisheng and Yang, Yang and Droby, Gaith and Wu, Di and Jena, Akankshya and Xie, Jialiu and Fedoriw, Yuri and Weissman, Bernard and Williams, Scott and Vaziri, Cyrus},
  title = {Differential roles of Rad18 in repressing carcinogen- and oncogene-driven mutagenesis in vivo},
  journal = {NAR Cancer},
  year = {2026},
  doi = {10.1093/narcan/zcag001}
}
Kostenlos starten →